Two Sigma Investments’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,734
| Closed | -$40K | – | 3413 |
|
|
2023
Q4 | $40K | Hold |
3,734
| – | – | ﹤0.01% | 2921 |
|
|
2023
Q3 | $22.4K | Sell |
3,734
-340
| -8% | -$2.04K | ﹤0.01% | 2787 |
|
|
2023
Q2 | $28.1K | Hold |
4,074
| – | – | ﹤0.01% | 2804 |
|
|
2023
Q1 | $64K | Sell |
4,074
-4,678
| -53% | -$73.4K | ﹤0.01% | 2645 |
|
|
2022
Q4 | $175K | Sell |
8,752
-9,060
| -51% | -$181K | ﹤0.01% | 2362 |
|
|
2022
Q3 | $318K | Buy |
17,812
+10,265
| +136% | +$183K | ﹤0.01% | 1906 |
|
|
2022
Q2 | $168K | Sell |
7,547
-2,004
| -21% | -$44.6K | ﹤0.01% | 2130 |
|
|
2022
Q1 | $266K | Buy |
9,551
+2,758
| +41% | +$76.8K | ﹤0.01% | 2213 |
|
|
2021
Q4 | $308K | Sell |
6,793
-15,831
| -70% | -$718K | ﹤0.01% | 2157 |
|
|
2021
Q3 | $1.89M | Sell |
22,624
-5,013
| -18% | -$418K | ﹤0.01% | 1397 |
|
|
2021
Q2 | $2.63M | Buy |
27,637
+22,089
| +398% | +$2.1M | 0.01% | 1205 |
|
|
2021
Q1 | $923K | Sell |
5,548
-3,707
| -40% | -$617K | ﹤0.01% | 1633 |
|
|
2020
Q4 | $907K | Buy |
+9,255
| New | +$907K | ﹤0.01% | 1380 |
|
|
2019
Q1 | – | Sell |
-938
| Closed | -$102K | – | 2521 |
|
|
2018
Q4 | $102K | Buy |
938
+193
| +26% | +$21K | ﹤0.01% | 1950 |
|
|
2018
Q3 | $164K | Buy |
+745
| New | +$164K | ﹤0.01% | 1889 |
|
|
2014
Q1 | – | Sell |
-8
| Closed | -$19K | – | 2324 |
|
|
2013
Q4 | $19K | Buy |
+8
| New | +$19K | ﹤0.01% | 2141 |
|